Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Event:
ESC Congress 2022
Topic:
Epidemiology, Prognosis, Outcome
Session:
Epidemiological aspects of atrial fibrillation
Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry